Men’s Health Most Recent
MD, FRCSC
Benign prostatic hyperplasia (BPH) is a common condition believed to exist in 50% of men age 60 or older, and 80% of men above the age of 80.
MD, FRCSC
Sacral Neuromodulation (SNM) is a FDA-approved minimally invasive surgical therapy offered as a third-line treatment for refractory overactive bladder (OAB).
Dr. Juan Carlos Monge spoke about the role of testosterone in the regulation of the cardiovascular system, as well as about the effects of hypogonadism and testosterone replacement on some cardiovascular risk factors.
L’aspect sécurité en ce qui concerne la prostate, est d’une importance clinique chez les hommes qui reçoivent une thérapie de remplacement de l’androgène.
MD, FRCPC
Le Dr Jeremy Gilbert a discuté de la pertinence clinique du lien entre le diabète de type 2/ le syndrome métabolique, et l’hypogonadisme parmi les hommes vieillissants.
Le Dr Juan Carlos Monge a parlé du rôle de la testostérone dans la régulation du système cardiovasculaire, ainsi que des effets de l’hypogonadisme et du remplacement de la testostérone sur certains facteurs de risque cardiovasculaires.
Advertisement
MD, FRCPC
Dr. Jeremy Gilbert addressed the clinical relevance of the association between type 2 diabetes/the metabolic syndrome and hypogonadism among aging males.
In men receiving androgen replacement therapy, the safety aspects regarding the prostate are an area of clinical importance.
Sexual desire and activity continue well into later life, and advanced age alone is not a deterrent to a happy and healthy sex life; however, clinicians should be aware that the normal sexual response of men and women may change with aging.
Sexuality and sexual activity do not end when a person reaches a certain age. Sexual desire and activity continue well into later life, and age is not a deterrent to a happy and healthy sex life.
